Prolonged retention of liposomes in the pleural cavity of normal mice and high tumor distribution in mice with malignant pleural effusion, after intrapleural injection

References

• Antimisiaris SG, Kallinteri P, Fatouros DG. Liposomes and Drug Delivery Chapter 5.3 In Pharmaceutical Manufacturing Handbook: Production and Processes. Gad SC Editor. Hoboken, NJ: John Wiley & Sons, Inc. ISBN: 978-0-470-25958-0, 2008;443–550.
   Google Scholar
• Antimisiaris S, Mourtas S, Papadia K. Targeted si-RNA with liposomes and exosomes (extracellular vesicles): how to unlock the potential. Inter J Pharm. 2017;525(2):293–312. doi:10.1016/j.ijpharm.2017.01.056
   PubMedGoogle Scholar
• Bulbake U, Doppalapudi S, Kommineni N, Khan W. Liposomal formulations in clinical use: an updated review. Pharmaceutics. 2017;9(2):12. doi:10.3390/pharmaceutics9020012
   PubMed Web of Science ®Google Scholar
• Koudelka S, Turanek Knotigova P, Masek J, et al. Liposomal delivery systems for anti-cancer analogues of vitamin e. J Control Release. 2015;207:59–69. doi:10.1016/j.jconrel.2015.04.00325861728
   PubMedGoogle Scholar
• Fernandes E, Ferreira JA, Andreia P, et al. New trends in guided nanotherapies for digestive cancers: a systematic review. J Control Release. 2015;209:288–307. doi:10.1016/j.jconrel.2015.05.00325957905
   PubMed Web of Science ®Google Scholar
• Jantz MA, Antony VB. Pleural fibrosis. Clin Chest Med. 2006;27:181–191. doi:10.1016/j.ccm.2005.12.00316716812
   PubMed Web of Science ®Google Scholar
• Haber DA, Buckler AJ, Glaser T, et al. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms’ tumor. Cell. 1990;61:1257–1269. doi:10.1016/0092-8674(90)90690-G2163761
   PubMed Web of Science ®Google Scholar
• Park S, Schalling M, Bernard A, et al. The Wilms tumour gene WT1 is expressed in murine mesoderm-Derived tissues and mutated in a human mesothelioma. Nat Genet. 1993;4:415–420. doi:10.1038/ng0793-2688401592
   PubMed Web of Science ®Google Scholar
• Tada Y, Hiroshima K, Shimada H, et al. An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocol. SpringerPlus. 2016;5:195. doi:10.1186/s40064-016-1893-227026891
   PubMedGoogle Scholar
• Mubarak KK, Montes-Worboys A, Regev D, et al. Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis. Eur Respir J. 2012;39:133–140. doi:10.1183/09031936.0014101021737551
   PubMed Web of Science ®Google Scholar
• Tohda Y, Iwanaga T, Takada M, et al. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer. Chemotherapy. 1999;45(3):197–204. doi:10.1159/00000718310224342
   PubMedGoogle Scholar
• Greillier L, Monjanel-Mouterde S, Fraticelli A, et al. Intrapleural Administration of Pemetrexed. A Pharmacokinetic Study in an Animal Model. J Thorac Oncol. 2009;4:3. doi:10.1097/JTO.0b013e3181b6be12
   Web of Science ®Google Scholar
• Jomgeow T, Oji Y, Tsuji N, et al. Wilms’ tumor gene WT117AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Sci. 2006;97:259–270. doi:10.1111/j.1349-7006.2006.00169.x16630117
   PubMed Web of Science ®Google Scholar
• Medina LA, Calixto SM, Klipper R, Li Y, Phillips WT, Gions B. Mediastinal Node and Diaphragmatic Targeting after Intracavitary Injection of Avidin/99mTc-Blue-Biotin-Liposome System. J Pharml ScI. 2006;95:207–224.
   PubMed Web of Science ®Google Scholar
• Liu J, Wong HL, Moselhy J, Bowen B, Wu XY, Johnston MR. Targeting colloidal particulates to thoracic lymph nodes. Lung Cancer. 2006;51:377–386. doi:10.1016/j.lungcan.2005.11.00616413084
   PubMed Web of Science ®Google Scholar
• Batra H, Antony VB. The pleural mesothelium in development and disease. Frontiers in Physiol Membr Physiol and Membr Biophys. 2014;5:Art 284.
   Google Scholar
• Perez-Soler R, Shin DM, Siddik ZH, et al. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions. Clin Cancer Res. 1997;3(3):373–379.9815694
   PubMed Web of Science ®Google Scholar
• Siddik ZH, Perez-Soler R, Khokhar AR, et al. Clinical pharmacokinetics of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) (L-NDDP). Proc Annu Meet Am Assoc Cancer Res. 1991;32:176.
   Google Scholar
• Watanabe M, Boyer JL, Crystal RG, Vrh AA. 10-mediated genetic delivery of bevacizumab to the pleura to provide local anti-VEGF to suppress growth of metastatic lung tumors. Gene Ther. 2010;17:1042–1051. doi:10.1038/gt.2010.8720596059
   PubMed Web of Science ®Google Scholar
• Ando H, Kobayashi S, Lila ASA, et al. Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed. J Control Release. 2015;220:29–36. doi:10.1016/j.jconrel.2015.11.01726476173
   PubMed Web of Science ®Google Scholar
• Agalioti T, Giannou AD, Krontira AC. Mutant KRAS promotes malignant pleural effusion formation. Nat Comms. 2017;8:15205. doi:10.1038/ncomms15205
   PubMed Web of Science ®Google Scholar
• Zimmermann G, Papke B, Ismail S, et al. Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling. Nature. 2013;497(7451):638–642. doi:10.1038/nature1220523698361
   PubMed Web of Science ®Google Scholar
• Matloob AH, Mourtas S, Klepetsanis P, Antimisiaris SG. Increasing the stability of curcumin in serum with liposomes or hybrid drug-in-cyclodextrin-in-liposome systems: a comparative study. Inter J Pharm. 2014;476(1):108–115. doi:10.1016/j.ijpharm.2014.09.041
   PubMedGoogle Scholar
• Tsotas VA, Mourtas S, Antimisiaris SG. Dexamethasone incorporating liposomes: effect of lipid composition on drug trapping efficiency and vesicle stability. Drug Deliv. 2007;14(7):441–445. doi:10.1080/1071754070160353017994361
   PubMed Web of Science ®Google Scholar
• Markoutsa E, Papadia K, Giannou AD, et al. Mono and dually decorated nanoliposomes for brain targeting, in vitro and in vivo studies. Pharm Res. 2014;31(5):1275–1289. doi:10.1007/s11095-013-1249-324338512
   PubMedGoogle Scholar
• Papadia K, Giannou AD, Markoutsa E, et al. Multifunctional LUV liposomes decorated for BBB and amyloid targeting – B. In vivo brain targeting potential in wild-type and APP/PS1 mice. Eur J Pharm Sci. 2017;102:180–187. doi:10.1016/j.ejps.2017.03.01028285172
   PubMed Web of Science ®Google Scholar
• Antimisiaris SG. Preparation of DRV liposomes. Meth Mol Biol. 2017;1522:23–47.
   PubMedGoogle Scholar
• Stewart JCM. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem. 1980;104:10–14. doi:10.1016/0003-2697(80)90269-96892980
   PubMed Web of Science ®Google Scholar
• Marazioti A, Kairi CA, Spella M, et al. Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion. PLoS One. 2013;8(8):e71207. doi:10.1371/journal.pone.007120723967166
   PubMedGoogle Scholar
• Giannou AD, Marazioti A, Spella M, et al. Mast cells mediate malignant pleural effusion formation. J Clin Invest. 2015;125:2317–2334. doi:10.1172/JCI8032325915587
   PubMedGoogle Scholar
• Marazioti A, Lilis I, Vreka M, et al. Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion. Nat Comms. 2018;9(1):Art num 672. doi:10.1038/s41467-018-03051-z
   Google Scholar
• Xiang Y, Liang L, Wang X, Wang J, Zhang X, Zhang Q. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. J Control Release. 2011;152:402–410. doi:10.1016/j.jconrel.2011.03.01421435361
   PubMed Web of Science ®Google Scholar
• Piperoudi S, Fatouros D, Ioannou PV, Frederik P, Antimisiaris SG. Incorporation of PEG-lipids in arsonoliposomes results in formation of highly stable arsenic-containing vesicles. Chem Phys Lipids. 2006;139(2):96–106. doi:10.1016/j.chemphyslip.2005.11.00316405880
   PubMed Web of Science ®Google Scholar
• Stathopoulos GT, Zhu Z, Everhart MB, et al. Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion. Am J Respir Cell Mol Biol. 2006;34(2):142–150. doi:10.1165/rcmb.2005-0130OC16210694
   PubMedGoogle Scholar